Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients.
Front Immunol
; 12: 781843, 2021.
Article
in En
| MEDLINE
| ID: mdl-34956211
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antirheumatic Agents
/
Immunogenicity, Vaccine
/
COVID-19
/
BNT162 Vaccine
/
Multiple Sclerosis
Type of study:
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: